Loading...

Operating Data

Illumina Inc.

Illumina Inc. (ILMN)

Healthcare

Year
A/P
2013
Actual
2014
Actual
2015
Projected
2016
Projected
2017
Projected
2018
Projected
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
Revenue 1,421.181,861.322,437.773,192.744,181.545,476.567,172.659,394.0212,303.3416,113.6921,104.10
Revenue (%)
EBITDA 268.32665.42665.75871.941,141.981,495.651,958.852,565.513,360.044,400.655,763.53
EBITDA (%)
EBIT 134.16514.84451.96591.93775.261,015.351,329.811,741.652,281.042,987.483,912.70
EBIT (%)
Depreciation 134.16150.58213.79280.00366.72480.29629.04823.861,079.001,413.171,850.83
Depreciation (%)




EBIT (Operating profit)(Operating income)(Operating earning) = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT)
EBIT = (1*) (2*) -> operating process (leverage -> interest -> EBT -> tax -> net Income)
EBITDA = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT) + Depreciation + amortization
EBITA = (1*) (2*) (3*) (4*) company's CURRENT operating profitability (i.e., how much profit it makes with its present assets and its operations on the products it produces and sells, as well as providing a proxy for cash flow) -> performance of a company
(1*) discounting the effects of interest payments from different forms of financing (by ignoring interest payments),
(2*) political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill)
(3*) collections of assets (by ignoring depreciation of assets)
(4*) different takeover histories (by ignoring amortization often stemming from goodwill)